49. The impact and next steps for research led by Shannon Stott, PhD, and Brian Nahed, MD, MSc
Drs. Shannon Stott and Brian Nahed explain why their new technology is an important breakthrough for glioblastoma patients, and share what’s...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Advances at Mass General Cancer Center
This podcast is a companion to Mass General Cancer Center’s electronic publication, and both are centered around our investigators recent publications in high-profile journals. Each expert w...
Episodes
9 episodes
48. New techniques for capturing EVs from glioblastoma w/ Shannon Stott, PhD, & Brian Nahed, MD, MSc
Drs. Shannon Stott and Brian Nahed describe a new technique that uses microfluidics and engineered nanosurfaces to capture EVs released from...
47. Getting to know Shannon Stott, PhD, and Brian Nahed, MD, MSc
In this episode, Drs. Shannon Stott and Brian Nahed explain their backgrounds and share how they met and began working with each other.
46. The impact of the study on transit tumor cells through lymph node vasculature
In this episode, Ethel Pereira and Tim Padera share why the protocol in this study isn’t safe to use for humans yet, and what the next steps...
45. Transit Tumor Cells Through Lymph Node Vasculature with Ethel Pereira, PhD, and Tim Padera, PhD
Tim Padera, PhD, and research fellow, Ethel Pereira, PhD, provide insight into their study of transit tumor cells.
44. Getting to know Tim Padera, PhD
Listen to hear how Tim Padera made his way from being an engineer in Chicago to becoming a cancer researcher in Boston.
43. Getting to know Ethel Pereira, PhD
In this episode we’ll hear about Ethel Pereira’s background and how she became interested in science, and specifically in cancer research.
42. The future of David Miyamoto, MD, PhD, and his team’s research
Dr. David Miyamoto explains the impact of his research in prostate cancer, and mentions how it can potentially translate to bladder cancer.
41. New Technologies for Prostate Cancer with David Miyamoto, MD, PhD
Dr. David Miyamoto explains his study that examines new technology for treating prostate cancer.